Effect of Methotrexate Treatment on the Onset of Autoimmune Kidney Disease in Lupus Mice
スポンサーリンク
概要
- 論文の詳細を見る
In the present study, we examined the effects of methotrexate (MTX) on the development of autoimmune kidney disease in three kinds of autoimmune prone mice, NZB/NZW F1 (BWF1) mice, MRL/Mp-lpr/lpr (MRL/lpr) mice and NZW/BXSB F1 (WBF1) mice. The results showed that MTX delayed the appearance of proteinuria and prolonged survival of both BWF1 and MRL/lpr mice and inhibited the elevation of blood urea nitrogen (BUN) levels which accompanies the development of lupus nephritis. However, MTX treatment did not affect these in WBF1 mice. Furthermore, MTX could not suppress immunoglobulin G (IgG) class anti-deoxyribonucleic acid (DNA) and anti-trinitrophenol (TNP) antibody production in any variety of mice. These suggest that the therapeutic effect of MTX on BWF1 and MRL/lpr mice does not result in the suppression of IgG autoantibody production.
- 社団法人日本薬学会の論文
- 1992-08-25
著者
-
勝目 朝夫
Fuji-gotemba Research Laboratories Chugai Pharmaceutical Co. Ltd.
-
三原 昌彦
Fuji-gotemba Research Laboratories Chugai Pharmaceutical Co. Ltd.
-
竹田 泰久
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd.,
-
竹田 泰久
Fuji Gotemba Research Laboratories Chugai Pharmaceutical Co. Ltd.
-
竹田 泰久
Fuji-gotemba Research Laboratories Chugai Pharmaceutical Co. Ltd.
関連論文
- Lobenzarit Disodium (CCA) Inhibits in Vitro Immunoglobulin Production via Direct Interaction with B Lymphocytes
- Effect of Methotrexate Treatment on the Onset of Autoimmune Kidney Disease in Lupus Mice
- 129 経口抗アレルギー薬 AM-682に関する研究(第IV報)ヒト血中における主代謝物 AM-682-NH_2の抗アレルギー作用について
- 34 新化合物AM682・Naの抗アレルギー作用(抗アレルギー剤)